Kestra Medical Technologies, Ltd. (NASDAQ:KMTS - Get Free Report) traded up 2.5% on Monday . The company traded as high as $24.40 and last traded at $24.01. 80,622 shares changed hands during trading, a decline of 73% from the average session volume of 293,426 shares. The stock had previously closed at $23.43.
Wall Street Analysts Forecast Growth
Several research analysts have weighed in on the stock. Piper Sandler assumed coverage on shares of Kestra Medical Technologies in a research note on Monday. They set an "overweight" rating and a $27.00 target price for the company. Wells Fargo & Company began coverage on Kestra Medical Technologies in a research report on Monday. They set an "overweight" rating and a $28.00 price objective on the stock. Wolfe Research started coverage on Kestra Medical Technologies in a report on Monday. They issued an "outperform" rating and a $29.00 target price for the company. Bank of America began coverage on Kestra Medical Technologies in a report on Monday. They set a "buy" rating and a $30.00 price target on the stock. Finally, The Goldman Sachs Group initiated coverage on Kestra Medical Technologies in a research note on Monday. They issued a "neutral" rating and a $24.00 price objective for the company. One analyst has rated the stock with a hold rating and five have issued a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average target price of $27.67.
Read Our Latest Research Report on Kestra Medical Technologies
Kestra Medical Technologies Price Performance
About Kestra Medical Technologies
(
Get Free Report)
We are a commercial-stage, wearable medical device and digital healthcare company focused on transforming patient outcomes in cardiovascular disease using monitoring and therapeutic intervention technologies that are intuitive, intelligent, and connected. We have developed and are commercializing our Cardiac Recovery System platform, a comprehensive and advanced system that integrates monitoring, therapeutic treatment, digital health, and patient support services into a single, unified solution.
Recommended Stories
Before you consider Kestra Medical Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kestra Medical Technologies wasn't on the list.
While Kestra Medical Technologies currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
